Transurethral resection in saline vaporization

Evaluation of clinical efficacy and prostate volume

Hideo Otsuki, Yoshitaka Kuwahara, Takeo Kosaka, Takuji Tsukamoto, Kenzo Nakamura, Ryoichi Shiroki, Kiyotaka Hoshinaga

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Objective: To assess the efficacy and safety of transurethral resection in saline vaporization for symptomatic bladder outlet obstruction and the change in prostate volume. Methods: A total of 106 patients with symptomatic bladder outlet obstruction underwent transurethral resection in saline vaporization. The effectiveness of the treatment was evaluated using the International Prostate Symptom Score (IPSS), quality of life score, urinary peak flow, and prostate volume preoperatively and at 1, 3, 6, and 12 months postoperatively. To assess the treatment effect, the patients were divided into 3 groups according to the preoperative prostate volume: group 1 (≥45 cm 3, n = 40), group 2 (<45 but ≥65 cm 3, n = 34), and group 3 (<65 cm 3, n = 32). Results: The mean perioperative hemoglobin loss was 1.2 g/dL. The mean IPSS, quality of life score, and prostate volume decreased significantly from 24.3, 5.2, and 52.8 cm 3 to 11.1, 2.7, and 29.9 cm 3, respectively (P <.01) and the mean urinary peak flow had increased significantly from 7.3 to 15.1 (P <.01) at 1 month. Moreover, the IPSS, quality of life score, and prostate volume had significantly decreased to 8.8, 2.3, and 26.1 cm 3 at 3 months (P <.05). The investigation of groups classified by prostate size demonstrated that the IPSS in group 3 continued at a significantly lower level than that in groups 1 and 2. The prostate volume decreased gradually and resulted in 52.8% volume reduction for ≤12 months. No significant complications were seen; however, irritative symptoms occurred frequently (11.3%). Conclusion: Transurethral resection in saline vaporization was a safe and effective treatment option and was more efficacious for patients with a larger prostate. The bother scores and prostate volume gradually decreased for ≤12 months.

Original languageEnglish
Pages (from-to)665-669
Number of pages5
JournalUrology
Volume79
Issue number3
DOIs
Publication statusPublished - 2012 Mar
Externally publishedYes

Fingerprint

Volatilization
Prostate
Urinary Bladder Neck Obstruction
Quality of Life
Hemoglobins

ASJC Scopus subject areas

  • Urology

Cite this

Otsuki, H., Kuwahara, Y., Kosaka, T., Tsukamoto, T., Nakamura, K., Shiroki, R., & Hoshinaga, K. (2012). Transurethral resection in saline vaporization: Evaluation of clinical efficacy and prostate volume. Urology, 79(3), 665-669. https://doi.org/10.1016/j.urology.2011.09.044

Transurethral resection in saline vaporization : Evaluation of clinical efficacy and prostate volume. / Otsuki, Hideo; Kuwahara, Yoshitaka; Kosaka, Takeo; Tsukamoto, Takuji; Nakamura, Kenzo; Shiroki, Ryoichi; Hoshinaga, Kiyotaka.

In: Urology, Vol. 79, No. 3, 03.2012, p. 665-669.

Research output: Contribution to journalArticle

Otsuki, H, Kuwahara, Y, Kosaka, T, Tsukamoto, T, Nakamura, K, Shiroki, R & Hoshinaga, K 2012, 'Transurethral resection in saline vaporization: Evaluation of clinical efficacy and prostate volume', Urology, vol. 79, no. 3, pp. 665-669. https://doi.org/10.1016/j.urology.2011.09.044
Otsuki, Hideo ; Kuwahara, Yoshitaka ; Kosaka, Takeo ; Tsukamoto, Takuji ; Nakamura, Kenzo ; Shiroki, Ryoichi ; Hoshinaga, Kiyotaka. / Transurethral resection in saline vaporization : Evaluation of clinical efficacy and prostate volume. In: Urology. 2012 ; Vol. 79, No. 3. pp. 665-669.
@article{476fd850ddec413c982872725e53ef72,
title = "Transurethral resection in saline vaporization: Evaluation of clinical efficacy and prostate volume",
abstract = "Objective: To assess the efficacy and safety of transurethral resection in saline vaporization for symptomatic bladder outlet obstruction and the change in prostate volume. Methods: A total of 106 patients with symptomatic bladder outlet obstruction underwent transurethral resection in saline vaporization. The effectiveness of the treatment was evaluated using the International Prostate Symptom Score (IPSS), quality of life score, urinary peak flow, and prostate volume preoperatively and at 1, 3, 6, and 12 months postoperatively. To assess the treatment effect, the patients were divided into 3 groups according to the preoperative prostate volume: group 1 (≥45 cm 3, n = 40), group 2 (<45 but ≥65 cm 3, n = 34), and group 3 (<65 cm 3, n = 32). Results: The mean perioperative hemoglobin loss was 1.2 g/dL. The mean IPSS, quality of life score, and prostate volume decreased significantly from 24.3, 5.2, and 52.8 cm 3 to 11.1, 2.7, and 29.9 cm 3, respectively (P <.01) and the mean urinary peak flow had increased significantly from 7.3 to 15.1 (P <.01) at 1 month. Moreover, the IPSS, quality of life score, and prostate volume had significantly decreased to 8.8, 2.3, and 26.1 cm 3 at 3 months (P <.05). The investigation of groups classified by prostate size demonstrated that the IPSS in group 3 continued at a significantly lower level than that in groups 1 and 2. The prostate volume decreased gradually and resulted in 52.8{\%} volume reduction for ≤12 months. No significant complications were seen; however, irritative symptoms occurred frequently (11.3{\%}). Conclusion: Transurethral resection in saline vaporization was a safe and effective treatment option and was more efficacious for patients with a larger prostate. The bother scores and prostate volume gradually decreased for ≤12 months.",
author = "Hideo Otsuki and Yoshitaka Kuwahara and Takeo Kosaka and Takuji Tsukamoto and Kenzo Nakamura and Ryoichi Shiroki and Kiyotaka Hoshinaga",
year = "2012",
month = "3",
doi = "10.1016/j.urology.2011.09.044",
language = "English",
volume = "79",
pages = "665--669",
journal = "Urology",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Transurethral resection in saline vaporization

T2 - Evaluation of clinical efficacy and prostate volume

AU - Otsuki, Hideo

AU - Kuwahara, Yoshitaka

AU - Kosaka, Takeo

AU - Tsukamoto, Takuji

AU - Nakamura, Kenzo

AU - Shiroki, Ryoichi

AU - Hoshinaga, Kiyotaka

PY - 2012/3

Y1 - 2012/3

N2 - Objective: To assess the efficacy and safety of transurethral resection in saline vaporization for symptomatic bladder outlet obstruction and the change in prostate volume. Methods: A total of 106 patients with symptomatic bladder outlet obstruction underwent transurethral resection in saline vaporization. The effectiveness of the treatment was evaluated using the International Prostate Symptom Score (IPSS), quality of life score, urinary peak flow, and prostate volume preoperatively and at 1, 3, 6, and 12 months postoperatively. To assess the treatment effect, the patients were divided into 3 groups according to the preoperative prostate volume: group 1 (≥45 cm 3, n = 40), group 2 (<45 but ≥65 cm 3, n = 34), and group 3 (<65 cm 3, n = 32). Results: The mean perioperative hemoglobin loss was 1.2 g/dL. The mean IPSS, quality of life score, and prostate volume decreased significantly from 24.3, 5.2, and 52.8 cm 3 to 11.1, 2.7, and 29.9 cm 3, respectively (P <.01) and the mean urinary peak flow had increased significantly from 7.3 to 15.1 (P <.01) at 1 month. Moreover, the IPSS, quality of life score, and prostate volume had significantly decreased to 8.8, 2.3, and 26.1 cm 3 at 3 months (P <.05). The investigation of groups classified by prostate size demonstrated that the IPSS in group 3 continued at a significantly lower level than that in groups 1 and 2. The prostate volume decreased gradually and resulted in 52.8% volume reduction for ≤12 months. No significant complications were seen; however, irritative symptoms occurred frequently (11.3%). Conclusion: Transurethral resection in saline vaporization was a safe and effective treatment option and was more efficacious for patients with a larger prostate. The bother scores and prostate volume gradually decreased for ≤12 months.

AB - Objective: To assess the efficacy and safety of transurethral resection in saline vaporization for symptomatic bladder outlet obstruction and the change in prostate volume. Methods: A total of 106 patients with symptomatic bladder outlet obstruction underwent transurethral resection in saline vaporization. The effectiveness of the treatment was evaluated using the International Prostate Symptom Score (IPSS), quality of life score, urinary peak flow, and prostate volume preoperatively and at 1, 3, 6, and 12 months postoperatively. To assess the treatment effect, the patients were divided into 3 groups according to the preoperative prostate volume: group 1 (≥45 cm 3, n = 40), group 2 (<45 but ≥65 cm 3, n = 34), and group 3 (<65 cm 3, n = 32). Results: The mean perioperative hemoglobin loss was 1.2 g/dL. The mean IPSS, quality of life score, and prostate volume decreased significantly from 24.3, 5.2, and 52.8 cm 3 to 11.1, 2.7, and 29.9 cm 3, respectively (P <.01) and the mean urinary peak flow had increased significantly from 7.3 to 15.1 (P <.01) at 1 month. Moreover, the IPSS, quality of life score, and prostate volume had significantly decreased to 8.8, 2.3, and 26.1 cm 3 at 3 months (P <.05). The investigation of groups classified by prostate size demonstrated that the IPSS in group 3 continued at a significantly lower level than that in groups 1 and 2. The prostate volume decreased gradually and resulted in 52.8% volume reduction for ≤12 months. No significant complications were seen; however, irritative symptoms occurred frequently (11.3%). Conclusion: Transurethral resection in saline vaporization was a safe and effective treatment option and was more efficacious for patients with a larger prostate. The bother scores and prostate volume gradually decreased for ≤12 months.

UR - http://www.scopus.com/inward/record.url?scp=84857912139&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857912139&partnerID=8YFLogxK

U2 - 10.1016/j.urology.2011.09.044

DO - 10.1016/j.urology.2011.09.044

M3 - Article

VL - 79

SP - 665

EP - 669

JO - Urology

JF - Urology

SN - 0090-4295

IS - 3

ER -